Intercure (XTAE:INCR) ROCE % : 4.10% (As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Intercure ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Intercure's annualized ROCE % for the quarter that ended in Jun. 2023 was 4.10%.

Intercure ROCE % Historical Data

The historical data trend for Intercure's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure ROCE % Chart

Intercure Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-56.90

-3.29

-13.59

5.95

10.19

Intercure Quarterly Data
	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial															19.24	11.28	-2.96	4.65	4.10

Intercure ROCE % Calculation

Intercure's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	58.531	/	( ( (696.545 - 193.585)	+	(958.007 - 312.719) )	/ 2 )
	=	58.531	/	( (502.96	+	645.288)	/ 2 )
	=	58.531	/	574.124
	=	10.19 %

Intercure's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	26.156	/	( ( (875.679 - 233.41)	+	(841.845 - 207.752) )	/ 2 )
	=	26.156	/	( ( 642.269	+	634.093 )	/ 2 )
	=	26.156	/	638.181
	=	4.10 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Intercure (XTAE:INCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Intercure ROCE % Related Terms

Thank you for viewing the detailed overview of Intercure's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intercure (XTAE:INCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

INCR:USA

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.